NanoVibronix Announces Reverse Stock Split
Written by Emily J. Thompson, Senior Investment Analyst
0mins
Should l Buy ?
Source: Newsfilter
Reverse Stock Split Announcement: NanoVibronix, Inc. will implement a 1-for-10 reverse stock split effective August 11, 2025, reducing the number of outstanding shares from approximately 7.97 million to about 796,887, with trading on a split-adjusted basis starting August 12, 2025.
Company Overview: NanoVibronix specializes in non-invasive medical technologies, including acoustic-based therapeutic devices and the ENvue Navigation Platform for minimally invasive procedures, aiming to enhance patient care and safety across healthcare settings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
